Who comes in second? The race against sulfonylureas and DPP4s as add-on therapy

    loading  Checking for direct PDF access through Ovid

Abstract

Ou SM, Shih CJ, Chao PW, Chu H, Kuo SC, Lee YJ, et al. Effects on clinical outcomes of adding dipeptidyl peptidase-4 inhibitors versus sulfonylureas to metformin therapy in patients with type 2 diabetes mellitus. Ann Intern Med. 2015; 163(9):663–672.

Related Topics

    loading  Loading Related Articles